Stroke
An Introduction to Stroke
The majority of strokes (85%) are caused by acute ischaemia resulting from the blockage of a cerebral artery, leading to a loss of oxygenation in downstream brain tissue, and ultimately causing neuronal cell death and irreversible neurological damage. The remainder are haemorrhagic strokes, caused by intracerebral haemorrhage or subarachnoid haemorrhage. The treatment of ischaemic stroke has been transformed by advances in imaging technology, as well as the emergence of thrombolytic therapy and subsequent mechanical thrombectomy, sometimes facilitating complete recovery. The increasing use of direct oral anticoagulants is preventing stroke in patients with atrial fibrillation. Therapies targeting neuroinflammation after brain ischaemia, such as transplantation of mesenchymal stem cells, are also emerging as a potentially useful treatment option.
Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
touchCARDIO Future Leaders 2026 Following the successful introduction last year of our touchCARDIO Future Leaders, we are delighted to announce that nominations are now open for the 2026 edition. This initiative celebrates the next generation of pioneers in cardiology, those whose passion, ...
Europe loses 1.7 million lives each year to cardiovascular disease, a burden that costs billions and affects millions more. The Safe Hearts Plan sets out an ambitious shift toward prevention, earlier detection and recognition of lifelong genetic risk. As expectations rise, debate is already growing over whether the strategy can translate bold goals into measurable improvements in care and outcomes across the EU.
S3E1_What impact does sleep have on physicians and their patients? We all know sleep is important, but what happens when physicians don’t get enough? In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from ...
The touchCARDIO journal Heart International has once again seen an increase in its Journal Impact Factor (JIF), rising from 1.9 in 2024 to 2.3 in 2025.
The foramen ovale, an obligatory channel, allows placental oxygenated blood to directly reach the fetal arterial circulation and remains patent in 25% of the adult population.1Â Patency provides a potential gateway for venous emboli to reach the arterial circulation, potentially resulting ...
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
touchCARDIO is delighted to announce that Heart International has received an impressive new Impact Factor of 1.9 in the 2024 Journal Citation Reports (JCR). This achievement marks a notable increase from last year’s Impact Factor of 0.2 and highlights the journal’s growing influence in the cardiology field.
The European Stroke Organisation Conference (ESOC) 2023 will take place 24-26 May 2023 in Munich, Germany. The conference will include sessions, plenary lectures, and symposia, covering a wide range of topics related to stroke, including acute management, rehabilitation, imaging, epidemiology, and public ...
Atrial fibrillation (AF) is common place across the United States and globally, with high prevalence and complication of stroke. In this touchCARDIO interview, we speak with Dr Aloke Finn (Medical Director, CVpath Institute; Associate Professor, University of Maryland, College Park, ...
AF Symposium 2023 Atrial Fibrillation Stroke Left atrial appendage occlusion (LAAO) devices are implanted in the heart and are intended to reduce the risk of thromboembolism from the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation. AF Symposium is ...
The PROTECTED-TAVR trial studied the efficacy of using an embolic protection device (Sentinel® cerebral protection system) during transcatheter aortic valve replacement in reducing the incidence of stroke/disabling stroke. In this touchCARDIO interview, we speak with Dr Steven Messe (University ...
Cryptogenic stroke (CS) is a brain infarction that cannot be clearly attributed to cardioembolism, large-vessel atherosclerosis or small artery disease, despite extensive clinical evaluation.1Â It represents approximately one-third of all ischaemic strokes worldwide.2Â Stroke represents a major public health crisis, ...
Introduction: Cryptogenic stroke (CS) accounts for 30–40% of all ischaemic strokes and there is substantial evidence to suggest arrhythmogenic cardioembolic involvement following the development of atrial fibrillation (AF). CS related to AF are often devastating, with around 70% mortality or significant disability. ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
